• 제목/요약/키워드: ATC classification

검색결과 14건 처리시간 0.019초

의약 정보검색을 위한 ATC코드기반 매핑 스키마 설계 (Mapping Schema Design for Medicine Information Retrieval Based on ATC Code)

  • 김대식;김미혜
    • 한국융합학회논문지
    • /
    • 제12권3호
    • /
    • pp.53-59
    • /
    • 2021
  • 의약품 정보검색 서비스를 사용할 때 대표적인 검색방법은 ATC(Anatomic Therapeutic Chemical Classification) 코드를 사용하는 것이다. 기존의 ATC코드 기반 의약정보 검색은 주요 성분이 한가지인 단일제 검색에는 매우 유용하다. 하지만 복합제의 경우에는 검색 오류가 종종 발생하고 있다. 이 문제의 원인은 ATC코드 기반 검색은 단일제 ATC 코드를 패턴매칭하여 진행 된다는 것이다. 본 연구는 ATC코드기반 검색 시 주성분을 기준으로 복합제를 검색하는 요구사항 시나리오를 분석하여 ATC코드기반 매핑 스키마를 설계하였다. ATC코드기반 매핑 스키마는 복합제의 ATC코드와 복합제에 포함된 모든 단일제의 ATC코드를 저장한 스키마를 의미한다. 이 스키마를 사용한 ATC코드기반 검색은 단일제의 주성분으로 복합제를 검색하므로 기존 방법보다 높은 정확도를 가진다. ATC코드기반 매핑 스키마는 의사의 환자 처방 효율을 높일 수 있고 의약품 안전 사용 서비스의 정확도를 올릴 수 있을 것으로 기대된다.

정신신경용계 의약품의 치료군 중복처방 평가기준(안) 개발 (Development of Criteria for Therapeutic Duplications of Psycho-Nervous System Drugs)

  • 손현순;최윤영;이영숙;최경업;신현택
    • 약학회지
    • /
    • 제55권3호
    • /
    • pp.185-194
    • /
    • 2011
  • Therapeutic duplication (TD) is frequently reported inappropriate drug use in healthcare settings in Korea. This study was aimed to develop TD criteria for psycho-nervous system drugs (KFDA classification 117 and 119). ATC classification was used to determine therapeutic and/or chemical similarities among the 93 ingredients reviewed. Clinical practice guidelines, textbooks and product labels were referenced for principles and evidences of possible drug combination usage. 16 groups that listed ingredients to be considered as TD were established and the criteria would be helpful to prevent TDs.

국내에서 농약에 대한 급성경구독성등급법 적용 및 GHS 체계 도입 제안 (Application of Oral Acute Toxic Class Method and Globally Harmonized Classification System on Pesticide)

  • 정미혜;유아선;박경훈;김병석;이희동;이제봉;권오경
    • 농약과학회지
    • /
    • 제12권2호
    • /
    • pp.141-147
    • /
    • 2008
  • 최근 국제적으로 화학물질에 대하여 분류체계를 단일화하기 위하여 "화학물질의 분류표지 등에 대한 세계 조화시스템(Globally Harmonized classification system, GHS)" 분류체계를 도입하고 있고, 또한 동물보호법에 따라 실험동물수를 축소한 급성경구독성시험법-고정용량법, 급성독성등급법(acute toxic class method, ATC), Up-and Down법을 새롭게 적용하고 있다. 본 시험은 국내 농약 등록시 수행하고 있는 급성경구독성시험인 $LD_{50}$ 시험법과 개정된 시험법 중 급성독성등급법(ATC)을 비교하여 새로운 시험법 적용과 GHS 분류체계 도입여부를 평가하기 위하여 실시하였다. 시험 농약은$LD_{50}$이 GHS 분류기준의 경계부분에 있는 농약 13종을 선발하여 $LD_{50}$ 시험법과 급성독성등급법을 동시에 수행한 결과 Methidathion EC, Parathion-ethyl의 $LD_{50}$$LD_{50}$ 시험법은 각각 57.3, $60\;mg\;kg^{-1}$ 이었고, 급성독성등급법은 $200\;mg\;kg^{-1}$ 으로 $LD_{50}$ 차이가 있었으나, GHS 분류체계의 독성구분 결과 모두 3급으로 동일하게 분류되었고, Carbofuran GR은 $LD_{50}$ 시험법은 $310\;mg\;kg^{-1}$, 급성독성등급법은 $300\;mg\;kg^{-1}$ 으로 비슷하였으나 GHS 분류 3급 기준이 $300\;mgvkg^{-1}$이하이므로 각각 4등급, 3등급으로 분류되었으며, Phosphamidon SL, Endosulfan EC, EPN EC, Dimethoate EC, Phenthoate EC, Zeta-cypermethrin EW, Bifenthrin EC, Fenthion EC, Carbaryl WP, Chlorpyrifos.Diflubenzuron WP의 $LD_{50}$ 은 두 시험 모두 비슷하였고, GHS 독성분류도 동일하였다. 이상의 결과 농약 등록시 급성경구독성시험에 급성독성등급법과 GHS 분류체계에 대한 적용가능성을 제시하고 있다.

국내 허가된 해열.진통.소염제의 치료중복 주의 가이드라인 개발 (Development of Drug Utilization Review Guidelines for Therapeutic Duplication of Antipyretics, Analgesics, and Anti-inflammatory Drugs Registered in Korea)

  • 이영숙;김남효;손현순;최경업;신현택
    • 한국임상약학회지
    • /
    • 제20권3호
    • /
    • pp.213-220
    • /
    • 2010
  • Therapeutic duplication (TD) is a serious problem that frequently occurring primarily in the ambulatory setting in Korea. Implementation of concurrent drug utilization review (DUR) is a promising way to reduce inappropriate prescription and dispensing, and improve patient safety. This study was aimed to develop the process of DUR module of TD. Sixty-five drug ingredients classified into the drug category of the antipyretic, analgesic, and anti-inflammatory drug approved in Korea (The KFDA-dess nated classification codes of 114 or 264) were reviewed for this purpose. The drug ingredients (and products) were reclassified based on WHO's Anatomical, Therapeutic and Chemical (ATC) classification system. The clinical practice guidelines, textbooks and product labels on therapeutic uses of these drugs in Korea and several fores n countries were reviewed. If the drugs were categorized into the same therapeutically duplicable class, they were defined not to be used concurrently because the concurrent use was "therapeutically duplicated (unnecessary or even harmful)". Among the studied drug products, the following 5 drug classes were considto beas "therapeutic duplication": (1), on-t tooid DURnti-inflammatory drugs (NSAIDs, including s Dicylates), (2),Anilidts, (3),Opioids, (4) Ergot Dk Doids and (5) 5-$HT_1$ receptor agonot s. Therefore, concurrent prescribing or dispensing of more than 2 drug ingredients any in the above same classes should be considered as TD and needed to be warrant for careful review by pharmacists before dispensing.

인적오류의 세부적 분류와 실증분석에 관한 연구 (A Study on the Detailed Classification and Empirical Analysis of Human Error)

  • 김양규;김칠영;최연철
    • 한국항공운항학회지
    • /
    • 제10권1호
    • /
    • pp.9-20
    • /
    • 2002
  • In aviation, it is important to analyse and classify human error in detail. Because human error has been implicated in 70 or 80% of aviation accidents in literature review. But, there is little detailed classification and research of human error. In this study, Objectives are to establish human error model by classifying types of human error in detail and also to analyse human factors by using the established model. Analysis of the data uses Korea Aviation Incidents Reporting System(GYRO). The resulting from actual analysis, there is a some difference between flight steps for human error occurrence and types of human error are different according to the aviation personnel(pilot, ATC controller).

  • PDF

외래 급성 상기도 감염에서의 항생제 사용량 및 약품비 추계 (Antibiotic Consumption and Expenditures for Acute Upper Respiratory Tract Infections in Outpatients)

  • 채수미;박은자;박실비아
    • 약학회지
    • /
    • 제57권3호
    • /
    • pp.199-204
    • /
    • 2013
  • This study aimed to quantify antibiotic consumption and expenditures for acute upper respiratory tract infections (URIs) (J00-J06) in outpatients from 2009 to 2011. We used WHO ATC classification and DDDs in measuring antibiotic consumption. National Health Insurance and Medical Aid claims data were analyzed. Antibiotic consumption has decreased from 4.44 DDD/1,000inhabitants/day in 2009, to 4.43 in 2010 and 3.74 in 2011. The estimated expenditures were 8,206 won/1,000inhabitants/day in 2009, 8,379 in 2010, and 7,004 in 2011. Clinics accounted for 89.8% and 86.0% of antibiotic consumption and expenditures respectively for the acute URIs in 2011. We need to monitor antibiotic consumption consistently, and promote judicious antibiotic use.

의약품 사용 관련 국내 통계자료에 나타난 성별 차이 조사 연구 (Investigation Study on Gender Difference Based on Korean Data Related to Drug Use)

  • 이수진;이병요;권광일
    • 한국임상약학회지
    • /
    • 제23권2호
    • /
    • pp.114-122
    • /
    • 2013
  • Background: Drugs should be evaluated in appropriate subjects representing potential population to take the drugs. This study focuses on gender factor and aims to make known the appropriateness of considering gender difference on clinical evaluation of drug with domestic data related to drug use. Methods: To understand gender difference shown in drug use, three types of domestic statistical data (prevalence of chronic disease, number of outpatient with major concerning disease, and consumption of medicine) were analyzed and compared according to gender. Results: Three of fifteen chronic diseases which were analyzed, showed significantly higher prevalence in women than in men, and three were vice versa. Meanwhile, the sex ratio of outpatients was significantly different in 22 major concerning diseases. Among the drug groups coded by Anatomical Therapeutic Chemical (ATC) Classification System, the consumption of most drug groups was generally higher in women than in men except for one group coded G (genito-urinary system and sex hormones). Conclusion: Gender difference should be considered in domestic clinical evaluation of drug and domestic guidance for reflecting gender difference should be established.

치매환자에서의 심혈관계 약물사용 분석 (Analysis of Cardiovascular Medication Use in Dementia Patients)

  • 유기연
    • 한국임상약학회지
    • /
    • 제27권3호
    • /
    • pp.136-142
    • /
    • 2017
  • Background: Dementia is one of important social and economic healthcare issues in the aging age. Therefore, it signifies to analyze the relationship between chronic disease or cardiovascular drug use and the incidence of dementia to establish a basis for increasing or preventing the risk of dementia. The purpose of this study was to investigate the correlation between the prevalence of chronic diseases and the use of cardiovascular drugs in patients diagnosed with dementia. Methods: In this study, we used data from sample of elderly patients from the Health Insurance Review and Assessment Service. We analyzed by logistic regression analysis with age, gender, and medication as covariates. KCD-7 was used to diagnosis of the disease, and drugs were analyzed using ATC codes and Korean standardized drug classification codes. Results: A total of 1,276,331 patients were analyzed in the sample of the elderly population, of which 532,075 (41.7%) were male and 744,256 (58.3%) were female. The patients have the higher risk of dementia in the older, women, and lower socioeconomically status. Cerebral infarction and ischemic heart disease increases risk of dementia. Patients taking statins, angiotensin converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonists (ARB) showed low incidence of dementia. Conclusion: This study has been shown that ACEI, ARB, and statin drugs may associate with lower incidence of Alzheimer's and other dementia except vascular dementia.

수정 델파이 기법을 이용한 의약품의 DDD(일일상용량) 결정과 항생제 사용량 분석: WHO 일일상용량이 없는 항생제를 중심으로 (Determination of Defined Daily Dose of Medicines using Nominal Group Technique and Analysis of Antibiotics Use in National Insurance Claim Data: Focused on Antibiotics without DDD of WHO)

  • 김동숙;김남순;이숙향
    • 한국임상약학회지
    • /
    • 제17권1호
    • /
    • pp.19-32
    • /
    • 2007
  • Objectives : It is necessary to monitor consumption of drugs in order to enhance promote appropriate use of drugs. Defined Daily Dose(DDD) of World Health Organization(WHO) has been used for evaluating the amount of medicine use. However, DDD of some drugs must be determined for drugs in Korea which are not listed by WHO. Our formulary follows ourself classification and DDD of some drugs must be determined since they exist only in Korea. This study was aimed to determine DDD value using RAND Appropriateness Methods and evaluate the amount of antibiotics use using DDD value. Methods : J01 antibiotics of WHO anatomical therapeutic chemical(ATC) classification were extracted from drug formulary. Antibiotics list without DDD was identified to determine their DDD with comprehensive review of references and recommendation of experts. defined. Review of reference was executed. of Expert panels were comprised of clinical pharmacist and clinical doctors. Modified Delphi Method was applied by survey and consensus meeting. Amount of antibiotic use was calculated by DDD/1000 inhabitants/day in the national level using health insurance claim data. Results : The result of 1 round, DDD values of 28 ingredients were determined from the first round of consensus meeting. With 2nd round meeting, 3 ingredients were deleted and DDD of 17 ingredients were decided. Analysis of antibiotic use in health insurance claim data showed 22.97 DDD/1000 inhabitants/day in 2003 year. Conclusion : This study can contribute to the establishment of DDD assignment and thus quantifying drug uses.

  • PDF

불안장애 환자에서의 치료약제 중복사용에 대한 후향적 의약품사용평가 연구 (Retrospective Drug Utilization Review Study on the Therapeutic Duplication in Patients with Anxiety Disorders)

  • 박찬현;손현순;신현택;최경업
    • 한국임상약학회지
    • /
    • 제20권1호
    • /
    • pp.39-49
    • /
    • 2010
  • The present study was aimed to examine the occurrence and influencing factors therapeutic duplication (TD) of medications for anxiety disorders by analyzing the relevant prescription data. In this study, the prescription data issued on March 19, 2008 in domestic medical institutes were utilized. TD was defined as more than two medications under the same therapeutic classification per prescription based on the Anatomical Therapeutic Classification (ATC) code. The assessment of TD was performed based on the number of cases and on the ratio determined. To identify the influencing factor of TD, the variables related to the differences in the TD ratio were analyzed based on the results of the Chi-Square test conducted with the variables; patients, medical institutes, diseases, and treatments. The number and ratio of TD were determined to be 1,333 out of the total of 19,219 anxiety disorder cases, and 6.94%, most cases involving benzodiazepine derivatives, respectively. The TD ratio was found to be higher in relation to males than to females. Patients with national health insurance benefits have a higher TD ratio compared to the medical-aid beneficiaries. The TD ratios were highest in clinics, psychiatry divisions, and Gyeongsang district. The TD ratio of the cases with more than two anxiety disorders was found to be higher than that of the cases with only one anxiety disorder. As the number of medications per prescription increased, the TD ratio was shown to have become gradually higher. In conclusion, in order to prevent TD, the concurrent DUR system should be implemented. The prescribers and pharmacists must be educated regarding duplicated medications to promote the safe and effective use of medicines, without unnecessary TD.